Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share Price (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    -1.40 (-2.95%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Faron Pharmaceuticals Share Price
Price 46.00 Open 46.00
Bid 45.00 High 46.00
Ask 47.00 Low 45.50
Change -1.40 (-2.95%) Close 47.40
Volume 88,245
Currency GBX
Issue Country GB
Shares in Issue 199.51m
Market Cap £91.78m
PE Ratio -2.389112
EPS -19.25401
Year High 240.00
Year High Date 27-Aug-2025
Year Low 38.70
Year Low Date 29-Apr-2026
Dividend 0.00
Yield 0.00%
# Trades 15
Vol. Sold 27,289
Sold Value £12.01k
Vol. Bought 55,797
Bought Value £25.97k
Market Size 1,500
What if I invested £1,000 in Faron Pharmaceuticals?
£ 1,095.24 (+9.52%)
1 month ago
£ 859.81 (-14.02%)
3 months ago
£ 252.05 (-74.79%)
6 months ago
£ 213.95 (-78.60%)
1 year ago
Add FARN to WatchlistAdd FARN to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Faron Pharmaceuticals Oy Ord Npv (di)

Faron Pharmaceuticals is listed in the FTSE AIM 100, FTSE AIM All-Share indices.

Faron Pharmaceuticals is listed in the Medicine and Biotech sector.

Faron Pharmaceuticals Oy Ord Npv (di) is listed on the London Stock Exchange trading with ticker code FARN.L. It has a market capitalisation of £91.78m, with approximately 199.51m shares in issue. Over the last year, Faron Pharmaceuticals share price has been traded in a range of 201.30, hitting a high of 240.00, and a low of 38.70.

Faron Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in Turku, Finland. Founded in 2007, it focuses on developing novel treatments for severe medical conditions with significant unmet needs. The company's pipeline includes innovative therapies for cancer, acute respiratory distress syndrome (ARDS), and other life-threatening diseases. Faron Pharmaceuticals is committed to advancing its proprietary technologies and conducting rigorous clinical trials to bring effective solutions to patients. With a strong emphasis on scientific research and collaboration, Faron aims to improve patient outcomes and contribute to the advancement of global healthcare.

Some Videos You Might Like

What's Hot 14th April 2026


 

Wishbone Gold announce 2025...


Recent Share Trades for Faron Pharmaceuticals (FARN)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
05-Jun-2616:29:4247.006,000Buy*45.0047.002,820O Ordinary
05-Jun-2616:14:2447.0024,000Buy*45.0047.0011.28kO Ordinary
05-Jun-2616:14:0046.00159Unknown*45.0047.0073.14O Ordinary
Trade was executed as an SI
05-Jun-2616:13:5646.0025,000Buy*45.0046.0011.50kO Ordinary
05-Jun-2616:12:5446.00159Buy*45.0046.0073.14O Ordinary
05-Jun-2616:12:5446.00159Buy*45.0046.0073.14O Ordinary
Trade was executed as an SI
05-Jun-2613:37:1046.00159Buy*45.0046.0073.14O Ordinary
05-Jun-2613:37:1046.0056Buy*45.0046.0025.76O Ordinary
Trade was executed as an SI
05-Jun-2613:35:2244.0027,289Sell*45.0047.0012.01kO Ordinary
05-Jun-2611:51:0947.0099Buy*45.0047.0046.53O Ordinary
Trade was executed as an SI

Directors Deals for Faron Pharmaceuticals (FARN)

Announced Traded Action Notifier Price Currency Amount Holding
31-Mar-2630-Mar-26PlacingTuomo Pätsi held the position of Chairman at the time of this trade.Tuomo Pätsi0.50EUR400,002453,267
25-Mar-2624-Mar-26PlacingMarkku Jalkanen held the position of Non-Executive Director at the time of this trade.Markku Jalkanen0.50EUR100,0081,725,274
19-Mar-2617-Mar-26PlacingJuho Jalkanen held the position of CEO at the time of this trade.Juho Jalkanen0.50EUR6841,368
19-Mar-2617-Mar-26PlacingJuho Jalkanen held the position of CEO at the time of this trade.Juho Jalkanen0.50EUR6841,368
19-Mar-2617-Mar-26PlacingJuho Jalkanen held the position of CEO at the time of this trade.Juho Jalkanen0.50EUR1,4311,368
Faron Pharmaceuticals

We offer a promising immunotherapy candidate with a new target to fight cancer.

Faron Pharmaceuticals Home Page